We have been repeatedly assured LymPro continues to be on
We have been repeatedly assured LymPro continues to be on track for Q4 commercialization and revenue generation. Because the share price is at 8 cents and because some analyst makes outlandish predictions for low revenue and massive reverse splits, some investors start to have doubts about LymPro.
I simply don't understand why investors would start having doubts at this point. I wish those with doubts would sell their shares so they could tell the rest of us who remain confident that "we told you so" when the LymPro revenue fails to deliver. I'm confident they will deliver, based on everything I've learned over the last year about the industry needs for this diagnostic test, and what I learned from the data presented at the AD conference back in July.
A single analyst tosses out a seemingly ridiculous low revenue number (based on what?) and this causes investors to start having major concerns and forget all we've learned about the science and the significant need for this test? Not to mention all the testing and work done to get us to the point of commercialization. Does anyone seriously believe the company did no analysis of revenue expectations while working with AD researchers and KOLs before committing to this launch? Do you believe Jason has access to this internal analysis?
Wow! Amazing! Seriously, some here need to stick to mutual fund investing. You don't have the capacity to do critical thinking to assess the reality of a situation.
I'm done here for the evening. Have fun with all of the headless chickens running around the yard.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shockwaves from Yulin: A Landmark Victory Out of the blue, the news from Yulin is stirring emotions worldwide. All dog slaughterhouses in Yulin, a city notorious for its gruesome dog meat festival, have been reportedly demolished. The city plans to impose a ban on dog meat, a radical shift unimaginable a decade ago. For animal rights advocates, it's an invigorating shot...
Continue Reading
Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...
Continue Reading
Bracing For Impact: The Tough Truth About West Fraser's Recent Moves Things are looking a bit bleak over at West Fraser Timber Co. They've just dropped their Q3 2026 results, ringing the bell with a hefty $80 million loss. As if that wasn't enough, the company's decided to indefinitely curtail a couple of mills—one in Lanett, Alabama and the other in Leola, Arkansas....
Continue Reading
Not Just Hype: Saab and GA-ASI's Breakthrough Here's a story that might just knock the socks off anyone paying attention to the defense sector. Saab and General Atomics Aeronautical Systems, Inc. (GA-ASI) have announced a major leap forward—the successful flight test of the LoyalEye AEW capability on an MQ-9B pilotless aircraft. They've managed to take a concept that...
Continue Reading
Paving the Way for Autonomous Transport Down Under Here's the scoop: NTRO and TIER IV are making waves with a groundbreaking project in Australia. They've roped in a 15-seater autonomous bus, crafted by TIER IV, to showcase the future of public transit. This isn't your average roll-out; it's a tactical move aimed at reshaping transport across Australia and New Zealand....
Continue Reading
Uwharrie Capital's Financial Dance Well, don't dust off the neon ticker tape quite yet but Uwharrie Capital Corp (OTCQX:UWHR) gave us a reason to nod approvingly over our espresso this quarter. From a scrappy hometown operation to a regional bank showing its mettle, the numbers they've laid down ain't half bad. Assets Climb a Billion-Dollar Ladder First thing that jumps...
Continue Reading
A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...
Continue Reading
An Overlooked Powerhouse: Geothermal Heat in Industry These days, it feels like everyone’s got their head in the clouds about renewables—think wind and solar. But under the surface, literally, is geothermal energy, waiting to make a play in Europe’s industrial sector. Project InnerSpace and Future Cleantech Architects are spotlighting a sleeping giant with their...
Continue Reading
Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...
Continue Reading
Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...
Continue Reading
ws Section End -->
Top 5 Most Recently Viewed Articles
Understanding the Myopia and Presbyopia Treatment Market The myopia and presbyopia treatment market is on the verge of substantial growth as the demand for effective solutions rises. The global estimates suggest an anticipated growth of USD 9.76 billion during the period from 2024 to 2028, showcasing a considerable compound annual growth rate (CAGR) of 9.05%. This growth...
Continue Reading
Navigating the Challenges of Rising Tariffs in Toy Industry The global toy industry faces considerable turbulence due to soaring tariffs, particularly those impacting products manufactured in China. Over the years, these tariffs have risen dramatically, with some reaching as high as 145%. As a result, companies in this sector are grappling with unprecedented challenges,...
Continue Reading
Bill Gates' Investing Strategy With Berkshire Hathaway The Gates Foundation Trust has proudly expanded its portfolio, reaching a value of $47.78 billion. This substantial growth is largely attributed to its increasing stake in Berkshire Hathaway Inc. Class B shares, alongside a focused investment strategy revolving around only a handful of prominent stocks. Changes in the...
Continue Reading
The Fascinating World of Alston's Singing Mice COLD SPRING HARBOR, N.Y. — All mice are known for their squeaks; however, only a select few are recognized for their singing abilities. Among them is Scotinomys teguina, commonly referred to as Alston's singing mice, which originate from the lush cloud forests in Costa Rica. Cold Spring Harbor Laboratory (CSHL) is at the...
Continue Reading
Around every corner, artificial intelligence is taking another leap and leaving some legacy in its wake. It seems only fitting that with all the tech wizardry, we also invite trouble right onto our doorsteps—AI trouble. That's where AIM Intelligence finds its niche, backed now by NAVER D2SF's investment, shaping up to be the unsung hero of AI security. The era of...
Continue Reading